Woori Financial (316140.KS) Q2 2026 Earnings Preview: Indonesia Provisions Booked, ₩958B Rebound on July 24
Woori Financial reports H1 2026 results on July 24 at 16:00 KST. Q2 consensus: ~₩958B (approx. +2% YoY per FnGuide). CET1 record 13.6%; H2 buyback up to ₩350B in view.
Shinhan Financial Group (055550.KS) Q2 2026 Earnings Preview: NIM Lift, ₩5T Milestone, and Lotte Wildcard
Shinhan Financial Group reports Q2 on July 24. Consensus net profit ~₩1.61T (+4% YoY). NIM +1bp to 1.94%, CET1 ~13.5%, and Lotte Non-Life deal are the key watch points.
Hana Financial Group Q2 2026 Earnings Preview: Record Profit, NIM Expansion, and ₩650B H2 Buyback
Hana Financial reports Q2 2026 results July 24. Consensus ₩1.22–1.25T net income (+4–6% YoY), record quarter. Watches: NIM +3bp, ₩650B H2 buyback, Dunamu CET1.
Foreign Investors Net-Sold ₩12.4 Trillion in Korean Stocks in July — but They Are Buying Index ETFs
Foreign investors net-sold ₩12.44T in Korean equities in July (₩12.1T KOSPI + ₩338.1B KOSDAQ) but bought a net ₩593.7B in Korean ETFs. We decode what this divergence signals.
KB Financial (105560.KS) Q2 2026 Earnings Preview: Record Profit, Rate Hike, and H2 Buyback
KB Financial's H1 2026 earnings conference is July 23 at 16:00 KST. Consensus Q2 net profit ₩1.91T (+10%) — here are three things Korea investors must watch.
South Korea's Biggest FX Overhaul Since 1997 Opens Won to Foreign Investors — What It Means for KOSPI
South Korea unveiled its biggest forex reform since 1997: foreigners can open won-denominated accounts overseas from Jan 2027. Here's what KOSPI investors need to know.
Korea Market Week Ahead (July 20–25): SK Hynix Q2 Wednesday, Bank Earnings, Homeplus Verdict
SK Hynix Q2 lands Wed July 22 (OP consensus ₩60–65T, +551–606% YoY). KB Financial call Thu July 23. Homeplus ruling expected. Four key events July 20–25 plus CXMT IPO July 27.
KB Report: Korea Solo Households Rotated Into Stocks at Peak
KB Report: Korea Solo Households Rotated Into Stocks at Peak
Alteogen ALT-B4 Powers Keytruda SC as Celltrion and Samsung Bioepis Field Rival Korean SC Platforms
Alteogen ALT-B4 powers Keytruda SC with up to $890M MSD milestones. Celltrion and Samsung Bioepis now field rival Korean SC platforms ahead of Keytruda's 2028 patent cliff.
SKHY Lands in 11 Korean Active ETFs Six Days After Nasdaq Debut — Three Things to Watch Ahead of Q2 Earnings
SK Hynix ADR (SKHY) entered 11 Korean active ETFs within six days of its July 10 Nasdaq debut. Q2 results come July 22 — three factors every investor must track.
Ecopro BM Sets 2027 Solid Electrolyte Mass-Production Target as All-Solid-State Battery Race Heats Up in Korea
Korea's largest cathode material maker sets 2027 as its solid electrolyte mass-production target, disclosing a full all-solid-state battery roadmap with 30+ global companies verifying its pilot materials.
Korea Triples Chip ETF Deposit to ₩30M, Halts New Listings as 'SamNick' Funds Draw ₩7.3 Trillion
Korea's FSC tripled the minimum deposit for Samsung and SK Hynix leveraged ETFs to ₩30M and halted new listings after ₩7.3T in total net inflows as funds fell nearly 50%.